DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Seiwert TY, Burtness B, Mehra R. et al.
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): An open-label, multicentre, phase 1b trial.
Lancet Oncol 2016;
17: 956-965
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.